UTI Healthcare Fund - Direct Plan - Growth Option

Open Ended Schemes(Equity Scheme - Sectoral/ Thematic)Very High RiskISIN INF789F01TO9

NAV · 06-Jul-2026

₹375.5278

+8.37%

+15.38%

1Y (CAGR)

+15.35%

3Y (CAGR)

+27.47%

5Y (CAGR)

+15.61%

Since inception (CAGR)

+16.50%

NAV history

hover for values

Risk & SIP analytics

Q1 · TOP · 3Y in category

Volatility (3y)

13.42%

Downside dev (3y)

9.93%

Max drawdown (3y)

-15.9%

Sharpe (3y)

1.56

SIP XIRR (3y)

+20.34%

SIP XIRR (5y)

+21.78%

Calendar-year returns

2020 +68.9%2021 +20.4%2022 -11.3%2023 +39.6%2024 +44.3%2025 -2.2%

Top holdings

AMFI disclosure · 2026-01-01

DR REDDY'S LABORATORIES LTD.EQUITY SHARES

3.45%

AUROBINDO PHARMA LTD.EQUITY SHARES

2.98%

Fund facts

Fund managerKamal Gada

AUM₹12,168 Cr

Expense ratio1.21% · 2026-05-31

TER · AMFI officialDirect 1.31% · Regular 2.26% (2026-06-30)

Launch date27-May-1999

Plan typeOpen Ended · Equity

Min lumpsum₹5,000

Min SIP₹500

Lock-inNone

Volatility15.40

AMCUTI Asset Mgmt. Co. Ltd.

Objective · The primary objective of the scheme is to generate long term capital appreciation by investing predominantly in equity and equity related securities of companies/institutions engaged in the Healthcare Services Sector. However, there can be no assurance or guarantee that the investment objective of the scheme would be achieved.

scheme documents ↗